- Revenue rose to $411.5M led by 32% oncology unit growth and 33% Data & Applications revenue growth.
- GAAP EPS narrowed significantly to $(0.08) compared to $(0.46) in the prior-year period.
- Adjusted net income turned positive to $13.3M ($0.07 per share).
?? Positive AI Sentiment (+5.5 / 10)
Observed market reaction after signal
Peak +7.39%